Tag: venous stent
Sonorous gains US FDA IDE approval for “first” pivotal trial of...
Sonorous Neurovascular has announced that the US Food and Drug Administration (FDA) approved its investigational device exemption (IDE) earlier this month, authorising the company...
VS3 Medical receives US FDA Breakthrough Device designation to treat debilitating...
VS3 Medical has announced that the US Food and Drug Administration (FDA) has granted a Breakthrough Device designation to its VS3 system. According to...
Acandis gains German regulatory approval to launch SONIC study evaluating Silance...
Acandis has announced that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate the SONIC study...
Sonorous Neurovascular announces first Canadian enrolment in B-SILENT study
Sonorous Neurovascular has announced the first patient enrolment in Canada within its international B-SILENT study. The enrolment took place at the Ottawa Hospital (Ottawa,...
Serenity gains “landmark” US FDA humanitarian device exemption for novel cerebral...
Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company, has today announced a “landmark” US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for its novel...
Acandis gains regulatory approval to launch RESOLVE study evaluating Sirex stent...
Acandis has announced that it has received approval from the French national competent authority for medicines and health products, Agence Nationale de Sécurité du...
